Bringing the fundamentals into focus…
Back to Sutro Biopharma, Inc.
How Sutro Biopharma, Inc. stacks up
STRO · against 1,216 other Healthcare companies
Growth
10/ 100
Near the bottom of its peers.
Ranked #1,090 of 1,217 · scores higher than 10% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 10–19, including STRO · Click a bar to see the companies
Why growth scores 10?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth and 3-year revenue growth, which are weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 96% of peers. Revenue growth: -56.3% vs peer median 6.1%
- slower revenue growth over three years: weaker than 84% of peers. 3-year revenue growth: -7.0% vs peer median 5.8%
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = STRO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | STRO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | -56.3% | 6.1% | 4% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | -7.0% | 5.8% | 16% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around STRO| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 1,090 | 7.1B TWD (≈$221M) | 10 | 25 | |
| 1,090 | 5.6B JPY (≈$38M) | 10 | 55 | |
| 1,090 | 6.8B CNY (≈$946M) | 10 | 21 | |
| 1,090 | 2.7B CNY (≈$382M) | 10 | 46 | |
| 1,090 | 158M USD | 10 | 14 | |
| 1,090 | 113M USD | 10 | 23 | |
| 1,102 | 6.3B CNY (≈$878M) | 9 | 32 | |
| 1,102 | 3.5B CNY (≈$495M) | 9 | 48 | |
| 1,102 | 4.3B CNY (≈$608M) | 9 | 20 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score